453 related articles for article (PubMed ID: 28926640)
1. Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjögren's syndrome.
Chen FY; Lee A; Ge S; Nathan S; Knox SM; McNamara NA
PLoS One; 2017; 12(9):e0184916. PubMed ID: 28926640
[TBL] [Abstract][Full Text] [Related]
2. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
[TBL] [Abstract][Full Text] [Related]
3. Critical involvement of macrophage infiltration in the development of Sjögren's syndrome-associated dry eye.
Zhou D; Chen YT; Chen F; Gallup M; Vijmasi T; Bahrami AF; Noble LB; van Rooijen N; McNamara NA
Am J Pathol; 2012 Sep; 181(3):753-60. PubMed ID: 22770665
[TBL] [Abstract][Full Text] [Related]
4. Deciphering Molecular and Phenotypic Changes Associated with Early Autoimmune Disease in the Aire-Deficient Mouse Model of Sjögren's Syndrome.
Chen FY; Gaylord E; McNamara N; Knox S
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453645
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
[TBL] [Abstract][Full Text] [Related]
6. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
7. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.
Klinngam W; Janga SR; Lee C; Ju Y; Yarber F; Shah M; Guo H; Wang D; MacKay JA; Edman MC; Hamm-Alvarez SF
Sci Rep; 2019 Jul; 9(1):9559. PubMed ID: 31267034
[TBL] [Abstract][Full Text] [Related]
9. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome.
Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome.
Chen YT; Lazarev S; Bahrami AF; Noble LB; Chen FY; Zhou D; Gallup M; Yadav M; McNamara NA
Lab Invest; 2012 Apr; 92(4):556-70. PubMed ID: 22231738
[TBL] [Abstract][Full Text] [Related]
11. Lacrimal gland fluid secretion and lymphocytic infiltration in the NZB/W mouse model of Sjögren's syndrome.
Paranyuk Y; Claros N; Birzgalis A; Moore LC; Brink PR; Walcott B
Curr Eye Res; 2001 Sep; 23(3):199-205. PubMed ID: 11803482
[TBL] [Abstract][Full Text] [Related]
12. Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease.
Vijmasi T; Chen FY; Chen YT; Gallup M; McNamara N
Mol Vis; 2013; 19():1957-65. PubMed ID: 24068863
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Mesenchymal Stem Cells on Dry Eye in Sjogren Syndrome Mouse Model.
Shin S; Yoon SG; Kim M; Cheon EJ; Jeon Y; Lee HJ; Chung SH
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674547
[TBL] [Abstract][Full Text] [Related]
14. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice.
Kong L; Robinson CP; Peck AB; Vela-Roch N; Sakata KM; Dang H; Talal N; Humphreys-Beher MG
Clin Exp Rheumatol; 1998; 16(6):675-81. PubMed ID: 9844759
[TBL] [Abstract][Full Text] [Related]
15. Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice.
Turpie B; Yoshimura T; Gulati A; Rios JD; Dartt DA; Masli S
Am J Pathol; 2009 Sep; 175(3):1136-47. PubMed ID: 19700744
[TBL] [Abstract][Full Text] [Related]
16. Small proline-rich protein 1B (SPRR1B) is a biomarker for squamous metaplasia in dry eye disease.
Li S; Nikulina K; DeVoss J; Wu AJ; Strauss EC; Anderson MS; McNamara NA
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):34-41. PubMed ID: 18172072
[TBL] [Abstract][Full Text] [Related]
17. Lacrimal gland, cornea, and tear film in the NZB/NZW F1 hybrid mouse.
Gilbard JP; Hanninen LA; Rothman RC; Kenyon KR
Curr Eye Res; 1987 Oct; 6(10):1237-48. PubMed ID: 3677784
[TBL] [Abstract][Full Text] [Related]
18. An autoimmune response to odorant binding protein 1a is associated with dry eye in the Aire-deficient mouse.
DeVoss JJ; LeClair NP; Hou Y; Grewal NK; Johannes KP; Lu W; Yang T; Meagher C; Fong L; Strauss EC; Anderson MS
J Immunol; 2010 Apr; 184(8):4236-46. PubMed ID: 20237294
[TBL] [Abstract][Full Text] [Related]
19. Exocrinopathy resembling Sjögren's syndrome induced by a murine retrovirus.
Suzuki K; Makino M; Okada Y; Kinoshita J; Yui R; Kanazawa H; Asakura H; Fujiwara M; Mizuochi T; Komuro K
Lab Invest; 1993 Oct; 69(4):430-5. PubMed ID: 8231110
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor inhibitor gene expression suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis.
Zhu Z; Stevenson D; Schechter JE; Mircheff AK; Crow RW; Atkinson R; Ritter T; Bose S; Trousdale MD
Cornea; 2003 May; 22(4):343-51. PubMed ID: 12792478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
